Prof.Chin-HsiaoTseng Taiwan

Prof.Chin-HsiaoTseng
Prof. Dr. Tseng gained his MD degree in 1986 and his PhD degree in 1996 from the National Taiwan University. He has published more than 280 refereed papers and more than 10 book chapters. He has been invited by the International Agency for Research on Cancer/World Health Organization to coauthor a monograph on “Carcinogenicity of some drugs and herbal medicines”. He has acted as a Topic Editor for a Research Topic “Current Status and Emerging Health Problems Associated with Diabetes, in Asia and in Developing Countries” for Frontiers in Endocrinology in 2019. He has been listed as the World’s Top 2% Scientists in seven consecutive years from 2019 to 2025 in both the Career-long and the Single-year categories (Stanford University). He is ranked as the Top 0.039% of World Expert in Metformin according to Expertscape and has been bestowed the highest honor “Outstanding Contribution Award” by the Diabetes Association of Republic of China (Taiwan) on March 20, 2022.

21 MARCH

Time Session
10:20
11:10
[DAROC Special Lecture] 戴東原教授紀念演講
(Mandarin Session)
  • Understanding Biology of Type 2 Diabetes and Related Metabolic Disorders - In Memory of the Late Professor Tai Tong-Yuan
    Lee-Ming ChuangTaiwan Speaker Understanding Biology of Type 2 Diabetes and Related Metabolic Disorders - In Memory of the Late Professor Tai Tong-YuanType 2 diabetes mellitus is one of the major non-communicable diseases and has a huge medical and societal impact in recent years and the years to come. Earlier understanding of diabetes is mainly from descriptive observations and epidemiological studies, albeit that the criteria of dysglycemia was only finally revised in year 2010 (ADA) & 2011 (WHO). With advent of new technologies, research of diabetes has bloomed from molecular epidemiology to multi-omic studies. These advances have provided us an opportunity and challenge for better understanding and management of type 2 diabetes and related metabolic disorders. Based on several different unbiased approaches, such as family-based genome-wide linkage analyses, genome-wide association studies, and mRNA differential display, we had been able to tease out certain candidate genes which are responsible disease processes, including insulin resistance, adipogenesis, obesity, and type 2 diabetes. I will illustrate translational medical studies of the genes from each of those approaches, such as Ribosome Binding Protein 1 (RRBP1), adiponectin (ADIPOQ), Vascular Adhesion Protein (VAP1), nocturnin (NOCT), and Prostaglandin Reductase 2 (PTGR2), respectively. With the Stanford Asia–Pacific Program for Hypertension and Insulin Resistance (SAPPHIRe) cohort study, which was established in 1995, our ongoing studies not only provide us a better understanding of the genes/factors on metabolic disorders but also pave a path for developing potential treatment of insulin resistance and the related clinical disorders. References. 1. Diabetes (2005) 54: 1200–1206 2. Journal of Biomedical Science (2023) 30:13 3. J Clin Endocrinol Metab (2001) 86: 3815–3819 4. EMBO Molecular Medicine (2025) 17:938-966
  • Research on Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus
    Chin-Hsiao TsengTaiwan Speaker Research on Albuminuria in Taiwanese Patients with Type 2 Diabetes Mellitus
  • (TBC)
    Wei-Shiung Yang Speaker
102